Cite
Fujita N, Ono Y, Sano A, et al. Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease. Eur J Endocrinol. 2022;186(2):245-253doi: 10.1530/EJE-21-0901.
Fujita, N., Ono, Y., Sano, A., Kimata, M., Oyama, S., Hashimoto, K., Sato, I., Kudo, M., Miyashiro, Y., Fujikata, A., & Tanaka, Y. (2022). Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease. European journal of endocrinology, 186(2), 245-253. https://doi.org/10.1530/EJE-21-0901
Fujita, Naoya, et al. "Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease." European journal of endocrinology vol. 186,2 (2022): 245-253. doi: https://doi.org/10.1530/EJE-21-0901
Fujita N, Ono Y, Sano A, Kimata M, Oyama S, Hashimoto K, Sato I, Kudo M, Miyashiro Y, Fujikata A, Tanaka Y. Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease. Eur J Endocrinol. 2022 Jan 06;186(2):245-253. doi: 10.1530/EJE-21-0901. PMID: 34874894.
Copy
Download .nbib